India's pharma, traditional-medicine sectors face slowdown

05/8/2013 | PharmaBiz.com (India)

The global economic downturn coupled with government austerity measures have slowed the growth of the Indian pharmaceutical industry as well as the Ayurvedic sector. New regulations imposed by the EU to combat the influx of counterfeit medicines have also slowed exports. The best prospects for growth in Indian pharmaceuticals include developing generics and biosimilars, strengthening drug-manufacturing capability, restructuring businesses to allow mergers and acquisitions, and keeping a sharp focus on global markets, say Indian drug-company officials.

View Full Article in:

PharmaBiz.com (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC